|
AUTS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.43769498715119E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
5.624000E-03 |
| Normal-vs-Stage3 |
1.7575399999914E-05 |
| Normal-vs-Stage4 |
2.187000E-01 |
| Stage1-vs-Stage2 |
2.357900E-02 |
| Stage1-vs-Stage3 |
8.539000E-03 |
| Stage1-vs-Stage4 |
2.58809999997833E-06 |
| Stage2-vs-Stage3 |
7.372200E-01 |
| Stage2-vs-Stage4 |
1.153150E-01 |
| Stage3-vs-Stage4 |
2.308300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.28785870856518E-14 |
| Normal-vs-AfricanAmerican |
3.503900E-03 |
| Normal-vs-Asian |
1.719960E-01 |
| Caucasian-vs-AfricanAmerican |
6.286200E-01 |
| Caucasian-vs-Asian |
5.444400E-01 |
| AfricanAmerican-vs-Asian |
5.035200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.49889989309315E-10 |
| Normal-vs-Female |
5.11146680537422E-12 |
| Male-vs-Female |
4.557800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.827820E-02 |
| Normal-vs-Age(41-60Yrs) |
1.98097094283867E-12 |
| Normal-vs-Age(61-80Yrs) |
1.83939999898186E-08 |
| Normal-vs-Age(81-100Yrs) |
2.655800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.437600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.415000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.773600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.159600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.263600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.090800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.61740000000399E-05 |
| Normal-vs-Grade 2 |
1.62436730732907E-12 |
| Normal-vs-Grade 3 |
1.4265000003455E-07 |
| Normal-vs-Grade 4 |
3.817800E-01 |
| Grade 1-vs-Grade 2 |
6.816300E-02 |
| Grade 1-vs-Grade 3 |
7.375500E-04 |
| Grade 1-vs-Grade 4 |
2.83229995012846E-09 |
| Grade 2-vs-Grade 3 |
2.188600E-04 |
| Grade 2-vs-Grade 4 |
5.28466159721575E-14 |
| Grade 3-vs-Grade 4 |
1.58500000002615E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
9.887900E-02 |
| ccA subtype-vs-ccB subtype |
1.62436730732907E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.76659994913331E-09 |
| Normal-vs-N1 |
2.096100E-03 |
| N0-vs-N1 |
7.39779999481271E-08 |
|
|
